医薬品用シールの世界市場予測（～2023年）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 MARKET SEGMENTATION 17
1.3.2 REGIONS COVERED 17
1.4 YEARS CONSIDERED FOR THE STUDY 18
1.5 CURRENCY 18
1.6 LIMITATIONS 18
1.7 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY DATA 21
2.1.2.1 Key data from primary sources 21
2.1.2.2 Key industry insights 21
2.1.2.3 Breakdown of primary interviews 22
2.2 MARKET SIZE ESTIMATION 22
2.3 DATA TRIANGULATION 23
2.3.1 ASSUMPTIONS 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 29
4.1 ATTRACTIVE OPPORTUNITIES IN THE PHARMACEUTICAL PROCESSING SEALS MARKET 29
4.2 PHARMACEUTICAL PROCESSING SEALS MARKET, BY REGION 29
4.3 PHARMACEUTICAL PROCESSING SEALS MARKET IN NORTH AMERICA, BY COUNTRY AND APPLICATION, 2017 30
4.4 PHARMACEUTICAL PROCESSING SEALS MARKET, DEVELOPED VS DEVELOPING COUNTRIES 30
 
5 MARKET OVERVIEW 31
5.1 INTRODUCTION 31
5.1.1 DRIVERS 31
5.1.1.1 Increasing demand for OTC drugs 31
5.1.1.2 Increasing instances of chronic diseases 32
5.1.2 RESTRAINTS 32
5.1.2.1 Growing preference for refurbished equipment 32
5.1.3 OPPORTUNITIES 32
5.1.3.1 Growing elderly population 32
5.1.3.2 Growth of pharmaceutical manufacturing in the emerging economies 33
5.1.4 CHALLENGES 33
5.1.4.1 Increasing overall costs owing to dynamic regulatory measures 33
5.2 PORTER’S FIVE FORCES ANALYSIS 34
5.2.1 BARGAINING POWER OF SUPPLIERS 34
5.2.2 THREAT OF NEW ENTRANTS 35
5.2.3 THREAT OF SUBSTITUTES 35
5.2.4 BARGAINING POWER OF BUYERS 35
5.2.5 INTENSITY OF COMPETITIVE RIVALRY 35
5.3 MACROECONOMIC INDICATORS 36
6 PHARMACEUTICAL PROCESSING SEALS MARKET, BY MATERIAL 38
6.1 INTRODUCTION 39
6.2 METALS 40
6.2.1 ABILITY TO WITHSTAND HIGH PRESSURE AND TEMPERATURES MAKES METALS IDEAL FOR USE IN PHARMACEUTICAL PROCESSING SEALS 40
6.3 PTFE 41
6.3.1 GROWING MARKETS FOR O-RINGS AND GASKETS ARE DRIVING THE DEMAND FOR PTFE IN PHARMACEUTICAL PROCESSING SEALS 41
6.4 SILICONE 42
6.4.1 INHERENT PROPERTIES OF SILICONE BOOST ITS DEMAND FOR PHARMACEUTICAL PROCESSING SEALS 42
6.5 NITRILE RUBBER 43
6.5.1 INCREASING DEMAND FOR NITRILE RUBBER-BASED O-RINGS IS DUE TO ITS LOW COMPRESSION SET, HIGH TENSILE STRENGTH, AND HIGH ABRASION RESISTANCE PROPERTIES 43
6.6 EPDM 44
6.6.1 RESISTANCE TO CHEMICALS AND THERMAL REACTIONS IS ONE OF THE MAJOR PROPERTIES OF EPDM DRIVING ITS DEMAND FOR MAKING PHARMACEUTICAL PROCESSING SEALS 44
6.7 OTHERS 45
 
7 PHARMACEUTICAL PROCESSING SEALS MARKET, BY TYPE 46
7.1 INTRODUCTION 47
7.2 O-RINGS 48
7.2.1 INCREASING DEMAND FOR O-RINGS IN THE PHARMACEUTICAL INDUSTRY IS DUE TO THEIR COST-EFFECTIVENESS AND VERSATILITY 48
7.3 GASKETS 49
7.3.1 INCREASING DEMAND FOR PHARMACEUTICAL MANUFACTURING, ESPECIALLY IN THE DEVELOPING ECONOMIES IS DRIVING THE MARKET FOR GASKETS 49
7.4 LIP SEALS 50
7.4.1 GROWING PHARMACEUTICAL INDUSTRY IS DRIVING THE MARKET FOR LIP SEALS 50
7.5 D SEALS 50
7.5.1 INCREASING DEMAND FOR NEW AND INNOVATIVE PHARMACEUTICAL PRODUCTS IS DRIVING THE MARKET FOR D SEALS 50
7.6 OTHERS 51
8 PHARMACEUTICAL PROCESSING SEALS MARKET, BY APPLICATION 52
8.1 INTRODUCTION 53
8.2 MANUFACTURING EQUIPMENT 54
8.2.1 GROWING PHARMACEUTICAL INDUSTRY IS DRIVING THE DEMAND IN THE MANUFACTURING EQUIPMENT SEGMENT 54
8.3 OTHERS 55
9 PHARMACEUTICAL PROCESSING SEALS MARKET, BY REGION 57
9.1 INTRODUCTION 58
9.2 NORTH AMERICA 60
9.2.1 US 63
9.2.1.1 Growing pharmaceutical industry and healthcare expenditure are driving the US market for pharmaceutical processing seals 63
9.2.2 CANADA 64
9.2.2.1 Growing generic drugs market is influencing the pharmaceutical processing seals market positively in Canada 64
9.2.3 MEXICO 64
9.2.3.1 Growing aging population and growth in the biosimilar drugs segment are expected to drive the market for pharmaceutical processing seals 64
9.3 APAC 65
9.3.1 CHINA 69
9.3.1.1 Increasing aging population and healthcare spending are driving the market for pharmaceutical processing seals in China 69
9.3.2 JAPAN 70
9.3.2.1 Growing aging population is triggering the demand for pharmaceutical processing seals indirectly in Japan 70
 
9.3.3 INDIA 71
9.3.3.1 As the largest manufacturer of generic drugs, India is a prominent market for pharmaceutical processing seals 71
9.3.4 SOUTH KOREA 72
9.3.4.1 Growing market for biosimilar drugs is contributing to the market growth of pharmaceutical processing seals 72
9.3.5 INDONESIA 72
9.3.5.1 Growing middle-class population and healthcare expenditure are driving the market for pharmaceutical processing seals 72
9.3.6 REST OF APAC 73
9.4 EUROPE 74
9.4.1 GERMANY 76
9.4.1.1 Growing pharmaceutical industry due to constant R&D investments and increasing healthcare expenditures are driving the market in Germany 76
9.4.2 ITALY 77
9.4.2.1 Strong pharmaceutical manufacturing base and export market are driving the demand for pharmaceutical processing seals 77
9.4.3 SWITZERLAND 78
9.4.3.1 Concentration of major pharmaceutical companies propels the pharmaceutical processing seals market in the country 78
9.4.4 UK 78
9.4.4.1 Growing pharmaceutical industry due to the increasing elderly population has boosted the demand for pharmaceutical processing seals in the country 78
9.4.5 FRANCE 79
9.4.5.1 Strong healthcare system and government support to the healthcare industry are driving the market for pharmaceutical processing seals 79
9.4.6 SPAIN 80
9.4.6.1 High R&D spends in the pharmaceutical industry are driving the market for pharmaceutical processing seals 80
9.4.7 REST OF EUROPE 81
9.5 SOUTH AMERICA 81
9.5.1 BRAZIL 84
9.5.1.1 Growing generic drugs market drives the demand for pharmaceutical processing seals in the country 84
9.5.2 ARGENTINA 85
9.5.2.1 Huge investments in R&D activities in the pharmaceutical industry and the presence of strong locally-owned laboratories are the governing factors for the market 85
9.5.3 REST OF SOUTH AMERICA 85
 
9.6 MIDDLE EAST & AFRICA 86
9.6.1 SAUDI ARABIA 89
9.6.1.1 New government initiatives for the development of the pharmaceutical industry is driving the pharmaceutical processing seals market in the country 89
9.6.2 UAE 90
9.6.2.1 Growing pharmaceutical industry due to the development of generic drugs market is boosting the market for pharmaceutical processing seals in the UAE 90
9.6.3 REST OF MIDDLE EAST & AFRICA 91
10 COMPETITIVE LANDSCAPE 92
10.1 OVERVIEW 92
10.2 MARKET RANKING 92
10.3 COMPETITIVE SITUATION & TRENDS 94
10.3.1 NEW PRODUCT DEVELOPMENT 95
10.3.2 EXPANSION 95
10.3.3 MERGER & ACQUISITION 96
10.3.4 JOINT VENTURE 97
11 COMPANY PROFILES 98
(Overview, Products Offered, Recent Developments, SWOT Analysis, and MNM View)*
11.1 TRELLEBORG 98
11.2 FREUDENBERG GROUP 101
11.3 FLOWSERVE CORPORATION 104
11.4 JAMES WALKER 106
11.5 PARKER HANNIFIN CORPORATION 107
11.6 SAINT-GOBAIN 109
11.7 GARLOCK 111
11.8 JOHN CRANE 113
11.9 IDEX CORPORATION 115
11.10 MORGAN ADVANCED MATERIALS 118
11.11 TECHNO AD LTD. 120
*Details on Overview, Products Offered, Recent Developments, SWOT Analysis, and MNM View might not be captured in case of unlisted companies.
11.12 ADDITIONAL COMPANY PROFILES 121
11.12.1 AESSEAL 121
11.12.2 EAGLE INDUSTRY CO., LTD. 121
11.12.3 MARCO RUBBER & PLASTIC PRODUCTS INC. 121
11.12.4 PRECISION ASSOCIATES, INC. 121
11.12.5 MACLELLAN RUBBER LTD. 122
11.12.6 PERFORMANCE SEALING INC. 122
11.12.7 AMERICAN HIGH PERFORMANCE SEALS 122
11.12.8 DARCOID OF CALIFORNIA 122
11.12.9 TECHNETICS GROUP 123
11.12.10 C. OTTO GEHRCKENS GMBH & CO. KG SEAL TECHNOLOGY 123
11.12.11 VULCAN ENGINEERING LIMITED 123
11.12.12 SEALS & DESIGN INC. 123
11.12.13 WIKA ALEXANDER WIEGAND SE & CO. KG 124
11.12.14 INTEC SEALS 124
11.12.15 ETANNOR SEALING SYSTEM 124
11.12.16 CANADA RUBBER GROUP INC. 124
12 APPENDIX 125
12.1 DISCUSSION GUIDE 125
12.2 AVAILABLE CUSTOMIZATIONS 129
12.3 RELATED REPORTS 129
12.4 AUTHOR DETAILS 130